Here are five highlights:
1. ReBOSSIS is the sole biosynthetic bone scaffold with electrospun microfiber construction.
2. The product is designed for posterolateral spine procedures.
3. ReBOSSIS has yielded a 54 percent compression recovery rate.
4. Providers have used ReBOSSIS in more than 1,500 procedures.
5. ORTHOReBIRTH USA is a wholly owned subsidiary of ORTHOReBIRTH Co.
More articles on biologics:
Kleiner Device Labs unveils new spinal bone graft tool: 5 things to know
GI surgical sealant receives CE marking for sale in the EU — 5 insights
1st surgery to treat damaged cartilage with allogeneic stem cells in Japan — 6 key insights
